26 commercial payer policies list 83520. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
26 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 83520 |
|---|---|---|
| Alzheimer's Disease Tests | Sep 8, 2023 | Covered |
| Antepartum Fetal Surveillance | Oct 24, 2023 | Covered |
| Cardiac Resynchronization Therapy and Other Pacing/Defibrillator Treatments for Heart Failure | Sep 8, 2023 | Covered |
| Fetal Fibronectin, Inflammatory Biomarkers, and Salivary Hormone Testing for Preterm Labor | Apr 6, 2023 | Covered |
| Huntington's Disease | Sep 12, 2023 | Covered |
| Maternal Biomarker Screening for Fetal Conditions | May 5, 2023 |
| Covered |
| Prostate Cancer Screening | Jul 14, 2023 | Covered |
|---|
| Recurrent Pregnancy Loss | Feb 15, 2024 | Covered |
|---|
| Rituximab | Mar 4, 2024 | Covered |
|---|
| Salivary Tests | Aug 31, 2023 | Covered |
|---|
| Policy | Effective | Status of 83520 |
|---|---|---|
| Selected Blood, Serum and Cellular Allergy and Toxicity Tests | Jul 1, 2026 | Not covered |
| Selected Protein Biomarker Algorithmic Assays | Oct 1, 2026 | Not covered |
| Testing for Biochemical Markers for Alzheimer Disease | Jul 1, 2026 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Analysis of Proteomic and Metabolomic Patterns for Cancer Detection, Risk, Prognosis, or Treatment Selection | Mar 1, 2026 | Covered |
| Molecular Testing in the Management of Pulmonary Nodules | Dec 1, 2025 | Covered |
| Multi-biomarker Disease Activity Blood Test for Rheumatoid Arthritis | Sep 1, 2025 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Concert Genetic Testing: Gastroenterology | Not recorded | Referenced |
| Policy | Effective | Status of 83520 |
|---|---|---|
| Rheumatoid Arthritis: Biologic Markers and Pharmacologic Assessment | Oct 1, 2025 | Covered |